Developments and challenges of FLT3 inhibitors in acute myeloid leukemia

por Ge, Shuai-Shuai, Liu, Song-Bai, Xue, Sheng-Li
Publicado 2022

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports

por Wang, Bin-Ru, Wan, Chao-Ling, Liu, Song-Bai, Qiu, Qiao-Cheng, Wu, Tian-Mei, Wang, Jun, Li, Yan-Yan, Ge, Shuai-Shuai, Qiu, Yan, Shen, Xiang-Dong, Xue, Sheng-Li, Li, Zheng
Publicado 2021

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment

por Li, Zheng, Wang, Jun, Ge, Shuai-Shuai, Qiu, Qiao-Cheng, Du, Jia-Hui, Shan, Shuang-Shuang, Shen, Xiang-Dong, Wan, Chao-Ling, Wang, Bin-Ru, Wu, De-Pei, Qiu, Hui-Ying, Xue, Sheng-Li
Publicado 2022

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study

por Wang, Miao, Cao, Han-Yu, Tan, Kai-Wen, Qiu, Qiao-Cheng, Huang, Yuan-Hong, Ge, Shuai-shuai, Wang, Zi-Hao, Chen, Jia, Tang, Xiao-Wen, Wu, De-Pei, Xue, Sheng-Li, Li, Zheng, Dai, Hai-Ping
Publicado 2023

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report

por Huang, Si‐Man, Tao, Tao, Wan, Chao‐Ling, Wu, Tian‐Mei, Cao, Han‐Yu, Qiu, Yan, Shen, Xiang‐Dong, Wang, Bin‐Ru, Ge, Shuai‐Shuai, Li, Yan‐Yan, Zhang, Tong‐Tong, Wu, Bing, Xue, Sheng‐Li
Publicado 2023